Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Alcon's acquisitions, partnerships and new product launches support growth, but tariffs and intense competition remain key risks.
Zacks Investment Research9/4/2026Negative
ALC
Alcon AGNYSEHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$34.08B
P/E Ratio
53.82
EPS
$1.31
Beta
0.70
52W High
$87.22
52W Low
$61.84
50-Day MA
$70.37
200-Day MA
$74.46
Dividend Yield
0.51%
Profit Margin
5.92%
Forward P/E
17.86
PEG Ratio
1.27
About Alcon AG
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.
Fundamentals
| Revenue (TTM) | $10.86B |
| Gross Profit (TTM) | $6.21B |
| EBITDA | $2.40B |
| Operating Margin | 14.60% |
| Return on Equity | 2.94% |
| Return on Assets | 2.80% |
| Revenue/Share (TTM) | $22.21 |
| Book Value | $44.67 |
| Price-to-Book | 1.61 |
| Price-to-Sales (TTM) | 3.14 |
| EV/Revenue | 3.529 |
| EV/EBITDA | 14.05 |
| Quarterly Earnings Growth (YoY) | -44.60% |
| Quarterly Revenue Growth (YoY) | 8.70% |
| Shares Outstanding | $483.40M |
| Float | $481.83M |
| % Insiders | 0.20% |
| % Institutions | 66.02% |
Historical Volatility
HV 10-Day
12.20%
HV 20-Day
22.52%
HV 30-Day
23.75%
HV 60-Day
25.96%
HV Rank
26.6%
Volatility is currently contracting
Analyst Ratings
Consensus ($85.24 target)
3
Strong Buy17
Buy5
Hold1
Strong SellLatest News
Alcon: A Re-Rating In Eyesight
Alcon is a structurally advantaged ophthalmology leader with a durable equipment-to-consumables model and strong recurring revenue streams. At $72, ALC trades at ~18x forward earnings, reflecting mid-teens EPS growth but pricing in neither margin expansion nor pipeline optionality. Management targets 25% core operating margin by FY2027E, with current core EPS guidance raised to +12–15% growth and significant capital returns underway.
Seeking Alpha9/3/2026Positive
Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control
GENEVA--(BUSINESS WIRE)--Alcon Launches UNITY® M, a Premium Ophthalmic Microscope Delivering Precise Control.
Business Wire9/3/2026Neutral
Alcon Prices EUR 500 Million Senior Notes Offering
GENEVA--(BUSINESS WIRE)--Alcon Prices EUR 500 Million Senior Notes Offering.
Business Wire8/26/2026Neutral
Alcon: A Strong Company Trading Close To Its Intrinsic Value, Buy
Alcon reported strong core operating profit (barring a one-time non-cash $402 million charge) during the quarter, up 17%. The company raised its full-year 2026 profit forecast for the second consecutive quarter. My DCF valuation states the stock is undervalued by 5.52%. I rate ALC a buy.
Seeking Alpha8/17/2026Positive
Alcon Inc. (ALC) Q2 2026 Earnings Call Transcript
Alcon Inc. (ALC) Q2 2026 Earnings Call Transcript
Seeking Alpha8/11/2026Neutral
Alcon's Q2 Earnings and Revenues Surpass Estimates, Stock Climbs
ALC's Q2 earnings and sales beat estimates as equipment and ocular health gains lift results, while the company raises its 2026 EPS outlook.
Zacks Investment Research8/11/2026Positive
Eye care company Alcon raises profitability outlook, cuts tariff hit estimate
Swiss-American eye care company Alcon on Monday hiked its profit guidance and lowered its estimate for the full-year tariff impact to $40 million to $90 million, factoring in an anticipated refund of around $60 million from the U.S. government.
Reuters8/11/2026Positive
New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth
GENEVA--(BUSINESS WIRE)--New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth.
Business Wire8/10/2026Neutral
Aecom, Alcon And 3 Stocks To Watch Heading Into Monday
With U.S. stock futures trading mixed this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Benzinga8/10/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ALC and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/8/2026